NUK - logo
National and University Library, Ljubljana (NUK)
Naročanje gradiva za izposojo na dom
Naročanje gradiva za izposojo v čitalnice
Naročanje kopij člankov
Urnik dostave gradiva z oznako DS v signaturi
  • Pomen zamejitve bolezni in ocena sposobnosti bolnika za zdravljenje pljučnega raka = The value of standing and estimating patient's capacity for lung cancer therapy
    Debevec, Lučka
    Background Resection yields the best survival rate in non-small cell lung cancer, and also as an adju vant therapy to chemotherapy and radiation in small-cell lung cancer. Therefore it is suitable to ... search for patients with technically and medically operable tumours. Therefore it is necessary to perform the correct staging and estimation of a patient's capacity for the intended surgery. Knowledge of the capability and reliability of singular investigations and their proper sequencing enables clinical staging of the tumour. The selection of the best treatment modality is based on the last factor. The diagnostic procedure should be rational and short, and the selected treatment useful for recovery, prolongation of survival or at least the relief of symptoms. Conclusions Staging is based on TNM tumour classification. In the process and extent of staging it is necessary to carefully estimate and consider the patient's capacity, particularly clinical condition, performance status, age, comorbidity and pulmonary function, and toassess tumour resectability by imaging (X-ray, CT MRI, PET US) and invasive investigations (bronchoscopy, cervical mediastinoscopy, parasternal mediastinotomyand švideođthora- coscopy). Before final selection of treatment,modality microscopic verification of the tu- mour is needed. Exploratory thoracotomy remains the ultimate possibility for verificatication and estimation of resectability. In addition to the imaging investigations mentioned, in searching for distant metastases the following are also useful: bone scanning, fine needle biopsy of palpable or reachable lesions of the lymph nodes, skin, bone marrow, body fluids and parenchymal organs. Laboratorytests of blood, urine and other bodily fluids may also indicate thatthe tumour has spread. It is necessary to take into account, that negativetest results do not reliably exclude metastases.
    Type of material - article, component part
    Publish date - 2006
    Language - slovenian
    COBISS.SI-ID - 21520601